FDA Inspection 1102938 — Fenwal International, Inc.

Fenwal International, Inc. — FEI 2627511

The FDA completed an inspection of Fenwal International, Inc. on September 26, 2019 in Maricao, PR. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 6 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 26, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Maricao, PR (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
145121 CFR 211.113(b)Procedures for sterile drug products
184921 CFR 211.84(d)(6)Objectionable microbiological contamination
203121 CFR 211.194(a)Complete test data included in records
358221 CFR 211.105(a)Identification of containers, lines, equipment
438921 CFR 211.198(a)Procedures to be written and followed